BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/5/2021 10:20:18 AM | Browse: 431 | Download: 1253
 |
Received |
|
2020-12-12 11:51 |
|
Peer-Review Started |
|
2020-12-12 11:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-12-17 19:56 |
|
Revised |
|
2020-12-30 14:40 |
|
Second Decision |
|
2021-01-12 12:10 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-01-12 18:12 |
|
Articles in Press |
|
2021-01-12 18:12 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-01-24 08:31 |
|
Typeset the Manuscript |
|
2021-02-03 02:24 |
|
Publish the Manuscript Online |
|
2021-02-05 10:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-Qi Sun, Li-Si Peng, Jie-Fang Guo, Fei Jiang, Fang Cui, Hao-Jie Huang and Zhen-Dong Jin |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Shanghai Association for Science and Technology |
19411951602 |
| National Natural Science Foundation of China |
81770642 |
|
| Corresponding Author |
Zhen-Dong Jin, MD, PhD, Director, Director, Professor, Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Changhai Road No. 168 Yangpu District, Shanghai 200433, China. zhendongjin@163.com |
| Key Words |
Serum tumor markers; Diagnosis; Advanced cystic mucinous neoplasms; Mucinous cystic neoplasms; Intraductal papillary mucinous neoplasms |
| Core Tip |
The value of serum tumor markers (STMs) in predicting advanced cystic mucinous neoplasms (A-cMNs) has not been well studied except for carbohydrate antigen (CA) 19-9. Our study illustrates for the first time the potential value of multiple STMs in the diagnosis of A-cMNs. CA19-9 was the most accurate STM in predicting A-cMNs with a moderate ability. CEA, CA125 and CA724 showed a low ability to predict A-cMNs. CA125 may be specific to the diagnosis of advanced mucinous cystic neoplasms. CA242 was not identified as useful in predicting A-cMNs in our study. The combination of STMs could improve sensitivity in predicting A-cMNs. |
| Publish Date |
2021-02-05 10:20 |
| Citation |
Sun LQ, Peng LS, Guo JF, Jiang F, Cui F, Huang HJ, Jin ZD. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas. World J Gastroenterol 2021; 27(6): 501-512 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i6/501.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i6.501 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
